A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness
Drug Science Policy and Law January 1, 2023 Jaden Brandt 5 citations
Rapid advances in psychedelic medicine research compel healthcare leaders and legislators to plan how to expand access to these treatments while ensuring safety and effectiveness. The pharmacy profession has been largely absent from these discussions. This commentary reviews potential strategies for legal reform, professional regulation, and pharmacy operations concerning psilocybin and MDMA, using Canada as an example. It outlines possible paths for policy creation and clinical practice changes needed to integrate these agents into healthcare systems.